Skip to main content
SpringerLink
Log in

Lapatinib

Development of resistance to metastatic HER2-positive gastric cancer: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Jiao X-D, et al. Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: A case report. BMC Cancer 18: 206, 20 Feb 2018. Available from: URL: http://doi.org/10.1186/s12885-018-4116-0 - China

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lapatinib. Reactions Weekly 1697, 221 (2018). https://doi.org/10.1007/s40278-018-44777-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-44777-9

Search

Navigation